Cosmecca Korea Co Ltd

Cosmecca Korea's capital structure is characterized by a debt-to-equity ratio of 0.68, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.33, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess. However, the company's cash and equivalents are negative at -27,952,910 KRW, which, when combined with its long-term debt of 171,952,831,830 KRW, indicates a net cash outflow that could pose liquidity challenges. In terms of profitability, Cosmecca Korea's return on equity (ROE) of 0.1798 and return on assets (ROA) of 0.0719 suggest that the company is generating a relatively strong return for its shareholders and effectively utilizing its assets. These figures are in line with the industry's preferred metrics, which emphasize asset efficiency and shareholder returns. The company's operating income of 81,819,262,230 KRW and net income of 45,439,905,660 KRW further support its profitability. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification mentioned. This lack of diversification could expose the company to regional economic fluctuations and market-specific risks. The absence of detailed segment or geographic breakdowns in the provided data limits the ability to assess the extent of revenue concentration. Cosmecca Korea's growth trajectory is supported by its operating cash flow of 55,035,089,610 KRW and free cash flow of 10,586,832,890 KRW, which provide the company with the financial flexibility to invest in future growth opportunities. The company's capital expenditure of -61,451,530,440 KRW indicates a net outflow, which may be attributed to the repayment of capital or a reduction in investment in fixed assets. Analysts have provided a mean price target of 111,100.00 KRW and a median price target of 120,000.00 KRW, reflecting a generally positive outlook on the company's future performance. The risk assessment for Cosmecca Korea highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position and the presence of long-term debt suggest that it may need to secure additional financing in the future, which could lead to increased financial leverage and potential dilution. However, the low dilution risk indicates that the company is not currently under significant pressure to issue new shares. The key flags mentioned in the risk assessment, such as the negative net cash after subtracting total debt, underscore the importance of monitoring the company's liquidity position. Recent events and filings do not provide specific details on new product launches, strategic partnerships, or regulatory changes that could impact the company's operations. The absence of detailed information on recent events limits the ability to assess the company's current strategic direction and market positioning. Analysts have provided a mean recommendation of 1.77, which is slightly above the "buy" threshold, indicating a generally positive sentiment among analysts. The strong-buy count of 3 and the buy count of 10 further support this positive outlook.